Kitty Yale, Chief Development Officer

Akero Therapeutics

Kitty Yale, Chief Development Officer

Kitty has over twenty-five years of drug development experience in the biotechnology and pharmaceutical industries. Prior to joining Akero, she spent 17 years at Gilead, where she led global clinical operations and management of the company’s oncology, HIV, inflammation, and liver disease trials. As VP of Clinical Operations at Gilead, Kitty led global development programs resulting in eight drug approvals in the US, EMEA, Canada, Korea, Japan, and China. She holds a BSc in Applied Biology from Glasgow Caledonian University. Kitty lives in San Francisco with her husband Kevin and their 2 teenage daughters. She enjoys spending time together with her family and friends, hiking, skiing and cooking.

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"